Schildmann J, Grunke M, Kalden J R, Vollmann J
Abteilung für Medizinische Ethik und Geschichte der Medizin, Ruhr-Universität Bochum, Malakowturm-Markstr 258a, D-44799 Bochum, Germany.
J Med Ethics. 2008 Nov;34(11):775-9. doi: 10.1136/jme.2007.023705.
To elicit the perceptions and preferences of patients with rheumatoid arthritis regarding information and participation in treatment decision-making. To analyse the patients' narratives on the background of the ethical discourse on various approaches to treatment decision-making.
In-depth interviews with themes identified using principles of grounded theory.
22 patients with long-standing rheumatoid arthritis.
Qualitative data on patients' perceptions and preferences regarding information and participation in decision-making about treatment.
Decision-making about treatment has been described by the patients as a process consisting of different stages with shifting loci of control and responsibility. Patients initially received one treatment recommendation and were not aware of alternative treatment options. Those participants in this study who wanted information about negative effects of a treatment cited "interest in one's own health" and the potential "use of information" as reasons for their preference. The physicians' expert knowledge and clinical experience regarding the effects of medication were cited as arguments by patients for a treatment recommendation.
The patients' accounts of decision-making about treatment differ from models of physician-patient relationship that have been put forward in ethical discourse. These differences may be relevant with respect to the starting point of an ethical analysis of treatment decision-making. Patients' accounts with respect to a lack of information on treatment alternatives point to ethically relevant challenges regarding treatment decision-making in clinical practice.
了解类风湿性关节炎患者对于治疗决策中信息获取及参与的看法和偏好。基于关于各种治疗决策方法的伦理讨论背景,分析患者的叙述。
采用扎根理论原则确定主题进行深入访谈。
22名患有长期类风湿性关节炎的患者。
关于患者对治疗决策中信息获取及参与的看法和偏好的定性数据。
患者将治疗决策描述为一个由不同阶段组成的过程,控制权和责任的归属不断变化。患者最初会收到一种治疗建议,且并不知晓其他治疗选择。本研究中那些想要了解治疗副作用信息的参与者将“对自身健康的关注”和信息的潜在“用途”作为偏好的理由。患者将医生关于药物疗效的专业知识和临床经验作为接受治疗建议的依据。
患者对治疗决策的描述与伦理讨论中提出的医患关系模式不同。这些差异可能与治疗决策伦理分析的起点相关。患者关于缺乏治疗替代方案信息的叙述指出了临床实践中治疗决策在伦理方面的相关挑战。